Global Male Infertility Market

Global male infertility market by testing method (computer assisted semen analysis, DNA fragmentation technique, microscopic examination, oxidative stress analysis, sperm agglutination, sperm penetration assay, others), by treatment (assisted reproductive technology, medication), by region (Asia Pacific, Europe, North America, Rest of the World (RoW)), outlook & forecast, 2021-2027

SKU: MGH01524 Category: Region:

USD2,400.00

Description

Male infertility is any health issue in a man that lowers the chances of his female partner getting pregnant. Infertility can be caused by low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Gen Consulting Company predicts global male infertility market will grow from USD 2,355 million in 2020 to USD 3,292 million by 2027, achieving a CAGR of 4.9 percent, according to the latest edition of the Global Male Infertility Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global male infertility market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the male infertility industry.

The male infertility market is segmented on the basis of testing method, treatment, and region. The male infertility market is segmented as below:

By testing method:
– computer assisted semen analysis
– DNA fragmentation technique
– microscopic examination
– oxidative stress analysis
– sperm agglutination
– sperm penetration assay
– others

By treatment:
– assisted reproductive technology
– medication

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Aytu Biopharma, Inc., Bayer AG, CinnaGen Inc., EMD Serono, Inc., Endo International plc, Sandstone Diagnostics, Inc., Theramex HQ UK Limited, Vitrolife AB, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global male infertility market.
– To classify and forecast the global male infertility market based on testing method, treatment, and region.
– To identify drivers and challenges for the global male infertility market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global male infertility market.
– To identify and analyze the profile of leading players operating in the global male infertility market.

Why Choose This Report
– Gain a reliable outlook of the global male infertility market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Interested in this report? Get your FREE sample now!
Global Male Infertility Market

Please fill out our form and we will get back to you.